Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC [Phase 2]
The document describes a Phase 2 clinical trial evaluating pemetrexed with or without carboplatin as second-line treatment for advanced non-…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1-2 trial of XIAP antisense AEG35156 in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor [Phase 2]
A Phase 2 trial for patients with recurrent non-small cell lung cancer after prior chemotherapy and surgical tumor removal was terminated; r…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study evaluating pemetrexed plus cisplatin for brain metastases in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC. [Phase 2]
Phase 2 clinical trial evaluating the combination of oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Sorafenib in Resected Non-small Cell Lung Carcinoma [Phase 2]
This document reports that the Phase 2 trial of sorafenib in patients with resected non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-22Clinical Trial Update: Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer [Phase 2]
Phase 2 trial evaluating cetuximab with vinorelbine in elderly patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy [Phase 1, Phase 2]
A Phase 1/2 study evaluating the feasibility of high-dose accelerated conformal radiotherapy for non-small cell lung cancer; the trial has c…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy [Phase 3]
A Phase 3 clinical trial investigates whether adding celecoxib to chemotherapy improves survival in patients with advanced non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC [Phase 2]
Phase II study evaluating celecoxib with concurrent radiotherapy in stage II-III Non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of gefitinib (Iressa) for brain metastases from non-small cell lung cancer was terminated. The study was sponsored by AstraZ…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation [Phase 3]
A Phase 3 trial evaluating FDG-PET-CT scans to predict outcomes in lung cancer patients receiving concurrent chemoradiation has been termina…
-
CLINICAL_TRIALS trial_result · 2009-06-30Clinical Trial Update: Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. [Phase 1]
Phase 1 safety study evaluating individualized radiation dose determination for non-small cell lung cancer patients; the trial has completed…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Phase II Study of ZD6474 in Advanced NSCLC [Phase 2]
Phase II study of vandetanib (ZD6474) in advanced non-small cell lung cancer was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-06-22Clinical Trial Update: Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients [Phase 2]
This update covers the Phase 2 evaluation of BAY 59-8862 in taxane-resistant non-small cell lung cancer, noting that the trial has been comp…
-
CLINICAL_TRIALS trial_result · 2009-06-11Clinical Trial Update: Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 feasibility trial evaluating pemetrexed in combination with cisplatin or carboplatin as adjuvant therapy for non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2009-06-04Clinical Trial Update: Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer [Phase 2]
The document summarizes Phase 2 trial results assessing the safety and efficacy of S-8184 as second-line treatment for relapsed stage IIIB/I…
-
CLINICAL_TRIALS trial_result · 2009-06-02Clinical Trial Update: Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant pemetrexed and cisplatin before surgery in Non-Small-Cell Lung Cancer was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2009-06-01Clinical Trial Update: A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066) [Phase 1]
A Phase 1 trial evaluated carboplatin plus paclitaxel with MK-0683 in chemotherapy-naive non-small cell lung cancer; the study was terminate…
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]
Phase 2 study evaluating biweekly gemcitabine and docetaxel as first-line therapy for advanced non-small cell lung cancer in elderly patient…
-
CLINICAL_TRIALS trial_result · 2009-05-19Clinical Trial Update: Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy followed by pulsed docetaxel with concurrent radiation for non-small cell lung cancer; the study statu…
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial compared pemetrexed plus gemcitabine on 14-day vs 21-day schedules in advanced non-small-cell lung cancer. The study was ter…
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Phase II Iressa Versus Vinorelbine (INVITE) [Phase 2]
Phase II randomized trial INVITE comparing Iressa (gefitinib) to vinorelbine in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-23Clinical Trial Update: Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study [Phase 3]
Phase 3 trial comparing Iressa (gefitinib) with best supportive care in second/third-line non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-16Clinical Trial Update: Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 randomized study comparing GEMOX (gemcitabine/oxaliplatin) to CP (carboplatin/paclitaxel) in non-small cell lung cancer has complete…